T-Cell Project: Epidemiologic Component

NCT00705809 | Completed

• 2 other identifiers: 99990816308-C-N163
• Study Type: observational
• Target: 800
• Locations: 1 country
• Sites: 1

Brief Summary

Background:

• The T-Cell Project, sponsored by the International T-cell non-Hodgkin Lymphoma Study Group, is a consortium of institutions interested in achieving more detailed information on clinical and biological characteristics of T-cell lymphomas.
• The T-Cell Project serves as a repository for data on patients with peripheral T-cell lymphoma (PTCL) worldwide. Its overall goal is to improve T-cell subtype classifications and evaluate treatment strategies for each subtype. Objectives:
• To implement a standardized epidemiologic questionnaire into the ongoing T-Cell Project to allow evaluation of various potential risk factors for PTLCs. Eligibility:
• Untreated patients 18 years of age and older who were diagnosed with PTLC September 1, 2006, or later. Design:
• Patients complete a questionnaire containing the following information: Demographic information Smoking history and alcohol use Personal history or cancer History of cancer among first-degree relatives Medical history History of transplants History of blood transfusions Medication use Occupational and residential history Pesticide treatment
• The information collected is linked to clinical and pathologic information in the T-Cell Project database.

Conditions

Peripheral T-Cell Lymphoma

Keywords

Epidemiology; Peripheral T-Cell Lymphoma

Eligibility Criteria

• Age: 18 Years+
• Sex: all
• Healthy Volunteers: No
• Age Groups: Adult (18-64), Older Adult (65+)

You may qualify if:

• Age greater than or equal to 18 years
• Histologically confirmed Periperal T-cell lymphoma on or after September 1, 2006

You may not qualify if:

• Age less than 18 years
• Cases without histological confirmation
• Cases diagnosed prior to September 1, 2006

Sponsors & Collaborators

• National Cancer Institute (NCI): lead

Study Sites (1)

National Cancer Institute (NCI), 9000 Rockville Pike

Bethesda, Maryland, 20892, United States

Location

Related Publications (3)

• Delves PJ, Roitt IM. The immune system. Second of two parts. N Engl J Med. 2000 Jul 13;343(2):108-17. doi: 10.1056/NEJM200007133430207. No abstract available.

  PMID: 10891520 BACKGROUND

• Delves PJ, Roitt IM. The immune system. First of two parts. N Engl J Med. 2000 Jul 6;343(1):37-49. doi: 10.1056/NEJM200007063430107. No abstract available.

  PMID: 10882768 BACKGROUND

• Jones D, O'Hara C, Kraus MD, Perez-Atayde AR, Shahsafaei A, Wu L, Dorfman DM. Expression pattern of T-cell-associated chemokine receptors and their chemokines correlates with specific subtypes of T-cell non-Hodgkin lymphoma. Blood. 2000 Jul 15;96(2):685-90.

  PMID: 10887135 BACKGROUND

MeSH Terms

Conditions

Lymphoma, T-Cell, Peripheral

Condition Hierarchy (Ancestors)

Lymphoma, T-Cell; Lymphoma, Non-Hodgkin; Lymphoma; Neoplasms by Histologic Type; Neoplasms; Lymphoproliferative Disorders; Lymphatic Diseases; Hemic and Lymphatic Diseases; Immunoproliferative Disorders; Immune System Diseases

Study Design

• Study Type: observational
• Time Perspective: PROSPECTIVE
• Sponsor Type: NIH

Study Record Dates

• First Submitted: June 25, 2008
• First Posted: June 26, 2008
• Study Start: June 18, 2008
• Study Completion: July 20, 2011
• Last Updated: July 2, 2017

Record last verified: 2011-07-20

Locations

US (1)